In an intriguing move within the renewable energy sector, VivoPower, a company traded on Nasdaq, announced its plans to invest a substantial $100 million into acquiring shares of the privately held company Ripple. This decision underscores VivoPower’s commitment to integrating blockchain technology into its operations.
The acquisition, as presented by VivoPower, suggests that this investment translates into a notable equity stake valued at approximately 211 million XRP, equating to an estimated worth of about $696 million.

Insights on the Purchase Strategy
VivoPower plans to conduct a thorough examination of the deal over the next two months, ensuring all details align with Ripple’s management consent. This acquisition reflects a tactical movement where VivoPower seeks to secure significant equity akin to 211 million XRP, averaging about $0.47 per XRP.
Previously, the company highlighted a theoretical scenario involving 30 million XRP at a value of $3.29, showcasing their strategic valuation approach. With partners like BitGo and Nasdaq Private Market, VivoPower is setting up solid custodial and transaction methods to facilitate this share transfer process.
Understanding the Discount Mechanism
VivoPower’s calculation regarding Ripple’s substantial 41 billion XRP holdings plays a crucial role, indicating a projected 86% discount from the market price of XRP. This method emphasizes the XRP reserves as a primary asset, sidelining other valuable operating units within Ripple’s portfolio, such as RLUSD and Metaco.
The mathematics behind the acquisition is striking—VivoPower estimates that acquiring the total 41 billion XRP under similar conditions could demand up to $19 billion, significantly higher than its anticipated investment.
Market Reactions and Industry Trends
The announcement has sparked considerable interest among investors and market analysts. Other companies have also begun announcing their own XRP-related treasury strategies, with Trident Digital Tech planning to raise $500 million and Webus aiming for $300 million.
Additionally, reports have emerged concerning Wellgistics Health and Hyperscale Data, indicating these companies are also seeking to allocate funds toward XRP.
It’s crucial to note that the transaction pertains solely to Ripple shares without immediate transfer of XRP tokens to VivoPower. This investment strategy reflects a form of equity exposure related to the tokens rather than direct ownership.
The impending transaction is contingent upon not just Ripple’s management approval but also a range of standard closure conditions, which may incorporate transfer restrictions and potential lock-up periods.
VivoPower estimates that every $10 million invested in Ripple shares could lead to a corresponding $5.15 per-share valuation growth for VivoPower’s shareholders, contingent upon the ultimate terms of the deal.
Investors are advised to closely monitor VivoPower’s filings with the SEC and Nasdaq for further updates, including Ripple’s official response and any additional transaction details that may emerge.
Featured image sourced from VivoPower’s Facebook page; chart courtesy of TradingView.